Merck says molnupiravir has favourable benefit-risk assessment News item 04 December 2021 Pages: 1 - 1
Package insert altered for sclerosing cholangitis with atezolizumab News item 04 December 2021 Pages: 3 - 3
Reducing risk of brolucizumab-related intraocular inflammation News item 04 December 2021 Pages: 4 - 4
Voluntary recall of Sagent Pharmaceuticals' levetiracetam injection News item 04 December 2021 Pages: 5 - 5
Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador Clinical study 04 December 2021 Pages: 6 - 6
Exposure to valproate in women of childbearing age high in India Clinical study 04 December 2021 Pages: 8 - 8
No increase in stroke, MI or PE after Pfizer-BioNTech COVID-19 vaccine Clinical study 04 December 2021 Pages: 9 - 9
Pfizer-BioNTech COVID-19 vaccine safe in older Koreans Clinical study 04 December 2021 Pages: 10 - 10
Risk-benefit of AstraZeneca COVID-19 vaccination in Australia Clinical study 04 December 2021 Pages: 11 - 11
Tigecycline-associated liver injury in Chinese patients Clinical study 04 December 2021 Pages: 12 - 12